Literature DB >> 20661659

Intragastric balloon followed by diet vs intragastric balloon followed by another balloon: a prospective study on 100 patients.

Alfredo Genco1, Massimiliano Cipriano, Vincenzo Bacci, Roberta Maselli, Emanuela Paone, Michele Lorenzo, Nicola Basso.   

Abstract

Aim of this study is to compare the efficacy of BioEnterics Intragastric Balloon (BIB®) followed by diet with BIB followed by another BIB. A prospective study was designed: a homogeneous group of 100 obese patients (age range 25-35, BMI range 40.0-44.9, M/F ratio 1/4) was allocated into two groups according to procedure: BIB (6 months) followed by diet therapy (7 months; group A = 50 pts), BIB positioning followed by another BIB after 1 month (group B = 50 pts). Baseline demographics were similar in both groups (Group A 10M/40F; mean age 31.4 ± 2.6; range 25-35; mean weight 106.3 ± 12.5 Kg; range 88-150; mean BMI 42.6±2.7 Kg/m(2); range 40.2-43.8; Group B 10M/40F; mean age 32.1 ± 2.1; range 25-35; mean weight 107.1 ± 11.9 Kg; range 90-150; mean BMI 42.9 ± 2.3; range 40.2-43.9). In both groups, weight loss parameters (Kg, BMI, and % EBL) were considered. Statistics were by Fisher's exact test (p < 0.05 was considered significant). At the time of 1st BIB removal, weight loss parameters in both groups were not significantly different: Group A: mean weight was 83.7±19.1 (range 52-151); mean BMI 34.2 ± 3.9 (range 32.4-43.8); and mean %EBL 43.5 ± 21.1 (range 0-68). Group B: mean weight was 84.9 ± 18.3 (range 50-148); mean BMI 34.8 ± 3.3 (range 32.4-43.8); and mean % EBL 45.2 ± 22.5% (range 0-68). At the study end, weight loss parameters were significantly lower in patients who underwent consecutive BIB (p < 0.05): mean BMI was 30.9 ± 7.2 Kg/m(2) (range 24-40), and 35.9 ± 9.7 Kg/m(2) (range 34-42); mean % EBL was 51.9 ± 24.6% (range 0-100) and 25.1 ± 26.2% (range 0-100) in group B and A, respectively. As compared with diet, a second intragastric balloon can be positioned without difficulties, achieving good results with continuous weight loss.

Entities:  

Mesh:

Year:  2010        PMID: 20661659     DOI: 10.1007/s11695-010-0231-y

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  11 in total

1.  BioEnterics Intragastric Balloon (BIB): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients.

Authors:  A Genco; M Cipriano; V Bacci; M Cuzzolaro; A Materia; L Raparelli; C Docimo; M Lorenzo; N Basso
Journal:  Int J Obes (Lond)       Date:  2006-01       Impact factor: 5.095

2.  Intragastric balloon for high-risk super-obese patients: a prospective analysis of efficacy.

Authors:  Charalambos Spyropoulos; Evaggelos Katsakoulis; Nancy Mead; Konstantinos Vagenas; Fotis Kalfarentzos
Journal:  Surg Obes Relat Dis       Date:  2007 Jan-Feb       Impact factor: 4.734

3.  Meta-analysis: pharmacologic treatment of obesity.

Authors:  Zhaoping Li; Margaret Maglione; Wenli Tu; Walter Mojica; David Arterburn; Lisa R Shugarman; Lara Hilton; Marika Suttorp; Vanessa Solomon; Paul G Shekelle; Sally C Morton
Journal:  Ann Intern Med       Date:  2005-04-05       Impact factor: 25.391

4.  Is bariatric surgery necessary after intragastric balloon treatment?

Authors:  Luigi Angrisani; Michele Lorenzo; Vincenzo Borrelli; Monica Giuffré; Carmine Fonderico; Giuseppe Capece
Journal:  Obes Surg       Date:  2006-09       Impact factor: 4.129

5.  BioEnterics Intragastric Balloon: The Italian Experience with 2,515 Patients.

Authors:  A Genco; T Bruni; S B Doldi; P Forestieri; M Marino; L Busetto; C Giardiello; L Angrisani; L Pecchioli; P Stornelli; F Puglisi; M Alkilani; A Nigri; N Di Lorenzo; F Furbetta; A Cascardo; M Cipriano; M Lorenzo; N Basso
Journal:  Obes Surg       Date:  2005-09       Impact factor: 4.129

6.  What becomes of patients one year after the intragastric balloon has been removed?

Authors:  J Herve; C H Wahlen; A Schaeken; B Dallemagne; J M Dewandre; S Markiewicz; B Monami; J Weerts; C Jehaes
Journal:  Obes Surg       Date:  2005 Jun-Jul       Impact factor: 4.129

Review 7.  Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis.

Authors:  Iñaki Imaz; Carmen Martínez-Cervell; Elvira Elena García-Alvarez; Juan Manuel Sendra-Gutiérrez; Jesús González-Enríquez
Journal:  Obes Surg       Date:  2008-05-06       Impact factor: 4.129

8.  Brazilian multicenter study of the intragastric balloon.

Authors:  José A Sallet; João B Marchesini; Dyker S Paiva; Keila Komoto; Carlos E Pizani; Maurélio L B Ribeiro; Pablo Miguel; Alvaro M Ferraz; Paulo C Sallet
Journal:  Obes Surg       Date:  2004-08       Impact factor: 4.129

9.  Intragastric balloon or diet alone? A retrospective evaluation.

Authors:  Alfredo Genco; Stefano Balducci; Vincenzo Bacci; Alberto Materia; Massimiliano Cipriano; Giovanni Baglio; Maria Cristina Ribaudo; Roberta Maselli; Michele Lorenzo; Nicola Basso
Journal:  Obes Surg       Date:  2008-05-16       Impact factor: 4.129

10.  Laparoscopic sleeve gastrectomy versus intragastric balloon: a case-control study.

Authors:  Alfredo Genco; Massimiliano Cipriano; Alberto Materia; Vincenzo Bacci; Roberta Maselli; Luca Musmeci; Michele Lorenzo; Nicola Basso
Journal:  Surg Endosc       Date:  2009-01-24       Impact factor: 4.584

View more
  30 in total

1.  Intragastric balloon treatment of obesity: Long-term results and patient satisfaction.

Authors:  Aline El Haddad; Mohammad O Rammal; Assaad Soweid; Ala I Shararra; Fady Daniel; Mahmoud A Rahal; Yasser Shaib
Journal:  Turk J Gastroenterol       Date:  2019-05       Impact factor: 1.852

2.  Morbidly obese are ghrelin and leptin hyporesponders with lesser intragastric balloon treatment efficiency : ghrelin and leptin changes in relation to obesity treatment.

Authors:  Marko Nikolic; Marko Boban; Neven Ljubicic; Vladimir Supanc; Gorana Mirosevic; Borka Pezo Nikolic; Ruzica Krpan; Ljubica Posavec; Vanja Zjacic-Rotkvic; Miroslav Bekavac-Beslin; Petar Gacina
Journal:  Obes Surg       Date:  2011-10       Impact factor: 4.129

3.  One-year adjustable intragastric balloons: do they offer more than two consecutive nonadjustable 6-month balloons? A response to Genco et al.

Authors:  Jeffrey Brooks
Journal:  Obes Surg       Date:  2013-12       Impact factor: 4.129

4.  Effect of consecutive intragastric balloon (BIB®) plus diet versus single BIB® plus diet on eating disorders not otherwise specified (EDNOS) in obese patients.

Authors:  Alfredo Genco; Roberta Maselli; Francesca Frangella; Massimiliano Cipriano; Emanuela Paone; Valentina Meuti; Giovanni Baglio; Giovanni Casella; Michele Lorenzo; Nicola Basso; Redler Adriano
Journal:  Obes Surg       Date:  2013-12       Impact factor: 4.129

Review 5.  Randomized controlled trials in bariatric surgery.

Authors:  Chien-Pin Chan; Bing-Yen Wang; Ching-Yuan Cheng; Ching-Hsiung Lin; Ming-Chia Hsieh; Jun-Jiun Tsou; Wei-Jei Lee
Journal:  Obes Surg       Date:  2013-01       Impact factor: 4.129

6.  Adjustable intragastric balloon vs non-adjustable intragastric balloon: case-control study on complications, tolerance, and efficacy.

Authors:  Alfredo Genco; Daniela Dellepiane; Giovanni Baglio; Fulvio Cappelletti; Francesca Frangella; Roberta Maselli; Maria Chiara Dante; Romina Camoirano; Michele Lorenzo; Nicola Basso
Journal:  Obes Surg       Date:  2013-07       Impact factor: 4.129

7.  Intragastric balloon for obesity treatment: results of a multicentric evaluation for balloons left in place for more than 6 months.

Authors:  Alfredo Genco; Roberta Maselli; Francesca Frangella; Massimiliano Cipriano; Pietro Forestieri; Daniela Delle Piane; Francesco Furbetta; Giancarlo Micheletto; Franco Ciampaglia; Paola Granelli; Maurizio Zilli; Michele Lorenzo; Giorgio Di Rocco; Domenico Giannotti; Adriano Redler
Journal:  Surg Endosc       Date:  2014-12-06       Impact factor: 4.584

8.  Multi-centre European experience with intragastric balloon in overweight populations: 13 years of experience.

Authors:  Alfredo Genco; Gontrand López-Nava; Christian Wahlen; Roberta Maselli; Massimiliano Cipriano; Maria Mara Arenas Sanchez; Chantal Jacobs; Michele Lorenzo
Journal:  Obes Surg       Date:  2013-04       Impact factor: 4.129

Review 9.  Efficacy of First-Time Intragastric Balloon in Weight Loss: a Systematic Review and Meta-analysis of Randomized Controlled Trials.

Authors:  Alan A Saber; Saeed Shoar; Mahmoud W Almadani; Natan Zundel; Mohammed J Alkuwari; Moataz M Bashah; Raul J Rosenthal
Journal:  Obes Surg       Date:  2017-02       Impact factor: 4.129

10.  Elipse™, a Procedureless Gastric Balloon for Weight Loss: a Proof-of-Concept Pilot Study.

Authors:  Evzen Machytka; Ram Chuttani; Martina Bojkova; Tomas Kupka; Marek Buzga; Kathryn Stecco; Samuel Levy; Shantanu Gaur
Journal:  Obes Surg       Date:  2016-03       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.